Healthcare firm Guardian Pharmacy raises $112 million in US IPO
FILE PHOTO: Morning sunlight falls on the facade of the New York Stock Exchange (NYSE) building after the start of Thursday's trading session in Manhattan in New York City, New York, U.S., January 28, 2021. REUTERS/Mike Segar/File Photo
(Reuters) - Guardian Pharmacy, which provides pharmacy services to long-term healthcare facilities, raised $112 million in its U.S. initial public offering on Wednesday, valuing the company at about $852 million.
The Atlanta, Georgia-based firm priced its offering of 8 million shares of Class A common stock at $14 apiece, the low-end of its targeted range of $14 to $16 each.
The U.S. market for fresh listings is seeing a recovery in investor appetite, boosted by expectations of monetary policy easing by the country's Federal Reserve and market optimism for a soft landing.
Investors have been selective in backing companies, with those burning cash as least favored, after a two-year IPO market downturn that saw poor performance from a raft of recently public high-profile firms.
Guardian Pharmacy, which was founded in 2004, offers a suite of technology-enabled services designed to help residents of long-term health care facilities. It was operating 50 pharmacies serving roughly 174,000 residents, as of June 30.
For the full-year 2023, Guardian Pharmacy's revenue rose to $1.05 billion, compared with $908.9 million a year earlier.
More than two-thirds of the company's annual revenue over the past three years has been generated from residents in assisted living facilities, behavioral health facilities and group homes, the company said in a regulatory filing.
Guardian Pharmacy said the remainder of the revenue is generated from residents of skilled nursing facilities.
It turned a net profit of $37.7 million in 2023 versus $49.7 million a year earlier.
The company's shares will trade on the New York Stock Exchange under the ticker symbol "GRDN."
Raymond James, Stephens and Truist Securities are the underwriters of the offering.
(This story has been corrected to say that the company's valuation is about $852 million, not $869.3 million, in paragraph 1)
(Reporting by Disha Mishra and Manya Saini in Bengaluru; Editing by Alan Barona and Mrigank Dhaniwala)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- WhiteHawk Minerals Corp (WHK) PT Raised to $37 at Raymond James
- EU Commissioner Kos cancels trip to Serbia after planned tribute to Mladic
- Exclusive-US, China gear up for mid-September AI safety talks
Create E-mail Alert Related Categories
ReutersRelated Entities
Raymond James, IPOSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share